Differential effects of inosine monophosphate dehydrogenase (IMPDH/GuaB) inhibition in Acinetobacter baumannii and Escherichia coli

Author:

Peng Yutian1ORCID,Moffat John G.2,DuPai Cory3,Kofoed Eric M.1,Skippington Elizabeth3,Modrusan Zora4,Gloor Susan L.2,Clark Kevin2,Xu Yiming2,Li Shuxuan5,Chen Liuxi5,Liu Xingrong5,Wu Ping6,Harris Seth F.6,Wang Shumei7,Crawford Terry D.7,Li Chun Sing8,Liu Zhiguo8,Wai John8,Tan Man-Wah1ORCID

Affiliation:

1. Department of Infectious Diseases, Genentech Inc., South San Francisco, California, USA

2. Department of Biochemical and Cellular Pharmacology, Genentech Inc., South San Francisco, California, USA

3. Department of Bioinformatics, Genentech Inc., South San Francisco, California, USA

4. Department of Proteomic and Genomic Technologies, Genentech Inc., South San Francisco, California, USA

5. Department of Drug Metabolism and Pharmacokinetics, Genentech Inc., South San Francisco, California, USA

6. Department of Structural Biology, Genentech Inc., South San Francisco, California, USA

7. Department of Discovery Chemistry, Genentech Inc., South San Francisco, California, USA

8. WuXi AppTec Co., Ltd., Waigaoqiao Free Trade Zone, Shanghai, China

Abstract

ABSTRACT Inosine 5′-monophosphate dehydrogenase (IMPDH), known as GuaB in bacteria, catalyzes the rate-limiting step in de novo guanine biosynthesis and is conserved from humans to bacteria. We developed a series of potent inhibitors that selectively target GuaB over its human homolog. Here, we show that these GuaB inhibitors are bactericidal, generate phenotypic signatures that are distinct from other antibiotics, and elicit different time-kill kinetics and regulatory responses in two important Gram-negative pathogens: Acinetobacter baumannii and Escherichia coli . Specifically, the GuaB inhibitor G6 rapidly kills A. baumannii but only kills E. coli after 24 h. After exposure to G6, the expression of genes involved in purine biosynthesis and stress responses change in opposite directions while siderophore biosynthesis is downregulated in both species. Our results suggest that different species respond to GuaB inhibition using distinct regulatory programs and possibly explain the different bactericidal kinetics upon GuaB inhibition. The comparison highlights opportunities for developing GuaB inhibitors as novel antibiotics. IMPORTANCE A. baumannii is a priority bacterial pathogen for which development of new antibiotics is urgently needed due to the emergence of multidrug resistance. We recently developed a series of specific inhibitors against GuaB, a bacterial inosine 5′-monophosphate dehydrogenase, and achieved sub-micromolar minimum inhibitory concentrations against A. baumannii . GuaB catalyzes the rate-limiting step of de novo guanine biosynthesis and is highly conserved across bacterial pathogens. This study shows that inhibition of GuaB induced a bacterial morphological profile distinct from that of other classes of antibiotics, highlighting a novel mechanism of action. Moreover, our transcriptomic analysis showed that regulation of de novo purine biosynthesis and stress responses of A. baumannii upon GuaB inhibition differed significantly from that of E. coli .

Funder

HHS | NIH | National Institute of General Medical Sciences

Publisher

American Society for Microbiology

Reference73 articles.

1. Uncovering the mechanisms of Acinetobacter baumannii virulence

2. WHO. 2017. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. Vol. WHO/EMP/IAU/2017.12.

3. Pathogenic Escherichia coli

4. IMP Dehydrogenase: Structure, Mechanism, and Inhibition

5. Characteristics and Crystal Structure of Bacterial Inosine-5‘-monophosphate Dehydrogenase,

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3